Provided by Tiger Trade Technology Pte. Ltd.

JW THERAP-B

2.230
-0.090-3.88%
Volume:1.20M
Turnover:2.70M
Market Cap:927.68M
PE:-1.56
High:2.320
Open:2.320
Low:2.200
Close:2.320
52wk High:6.440
52wk Low:1.260
Shares:416.00M
HK Float Shares:416.00M
Volume Ratio:1.23
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.428
ROE:-51.67%
ROA:-12.23%
PB:0.91
PE(LYR):-1.56
PS:4.63

Loading ...

JW (Cayman) Therapeutics (02126) Announces Monthly Return as of 31 January 2026

Bulletin Express
·
Feb 05

JW (Cayman) Therapeutics (2126) Announces Grants of Share Options and Restricted Share Units

Bulletin Express
·
Jan 16

JW THERAP-B (02126) Grants 2.6 Million Share Options and 650,000 Restricted Share Units

Stock News
·
Jan 16

JW Cayman Therapeutics Announces Grant of Share Options and Restricted Share Units

Reuters
·
Jan 16

JW Cayman Therapeutics Files Director List with HKEX

Reuters
·
Dec 29, 2025

Is JW (Cayman) Therapeutics (HKG:2126) A Risky Investment?

Simply Wall St.
·
Dec 23, 2025

JW Cayman Therapeutics Extends Vector Supply Agreement with Juno

Reuters
·
Dec 22, 2025

JW THERAP-B (02126): Tian Feng Appointed as CEO

Stock News
·
Dec 12, 2025

JW Cayman Therapeutics Files Director List with HKEX

Reuters
·
Dec 12, 2025

JW Cayman Therapeutics Appoints Tian Feng as CEO and Executive Director

Reuters
·
Dec 12, 2025

JW (Cayman) Therapeutics - Tian Feng Will Be Appointed as Chief Executive Officer and as an Executive Director

THOMSON REUTERS
·
Dec 12, 2025

JW (Cayman) Therapeutics - DR. Cheng Liu Appointed as Chairman

THOMSON REUTERS
·
Dec 12, 2025

JW THERAP-B (02126) Presents JWCAR201 IIT Study Data at the 67th ASH Annual Meeting

Stock News
·
Dec 08, 2025

JW Therapeutics Presents JWCAR201 Clinical Study Data at Hematology Conference

Reuters
·
Dec 08, 2025

JW THERAP-B Surges Over 9% as CAR-T Therapy Breyanzi® Included in National Reimbursement Drug List

Deep News
·
Dec 08, 2025

JW (Cayman) Therapeutics Co. Ltd. (02126) Releases November 2025 Monthly Return

Bulletin Express
·
Dec 03, 2025

Imugene and JW Therapeutics Partner to Advance CAR-T and Oncolytic Virus Therapy for Solid Tumors

Reuters
·
Nov 28, 2025

BUZZ-Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment

Reuters
·
Nov 27, 2025

JW (Cayman) Therapeutics Co. Ltd (02126) Releases Monthly Return for October 2025

Bulletin Express
·
Nov 05, 2025

HK Stock Movement | JW THERAP-B (02126) Surges Over 10% as CAR-T Drug Reportedly Nears Commercial Insurance Coverage

Stock News
·
Nov 03, 2025